BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8440445)

  • 1. The kidneys in hepatic cirrhosis: victims of portal-systemic venous shunting (portal-systemic nephropathy).
    Sherlock S
    Gastroenterology; 1993 Mar; 104(3):931-4. PubMed ID: 8440445
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis.
    Bosch J; Gomis R; Kravetz D; Casamitjana R; Terés J; Rivera F; Rodés J
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G206-12. PubMed ID: 6383074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis.
    Demirci M; Tan E; Elibol B; Gedikoğlu G; Saribaş O
    Neurology; 1992 May; 42(5):983-5. PubMed ID: 1579253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
    Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.
    Riggio O; Efrati C; Catalano C; Pediconi F; Mecarelli O; Accornero N; Nicolao F; Angeloni S; Masini A; Ridola L; Attili AF; Merli M
    Hepatology; 2005 Nov; 42(5):1158-65. PubMed ID: 16250033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade].
    Bykov VS
    Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.
    Noiret L; Baigent S; Jalan R
    Liver Int; 2014 Jul; 34(6):e45-55. PubMed ID: 24134128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.
    Lee FY; Colombato LA; Albillos A; Groszmann RJ
    Gastroenterology; 1993 Nov; 105(5):1464-70. PubMed ID: 8224649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional nephropathy in the course of hepatic cirrhosis. Pathogenetic relationships with changes in hepatic blood flow].
    Merkel C; Zuin R; Grassetto M; Milani L; Merlo A; Gatta A
    Minerva Nefrol; 1979; 26(1):33-6. PubMed ID: 381989
    [No Abstract]   [Full Text] [Related]  

  • 13. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis.
    Moriya K; Kojima H; Matsumura M; Sakurai S; Imazu H; Uemura M; Honda H; Fukui H
    Hepatogastroenterology; 2003; 50(52):1128-32. PubMed ID: 12845996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
    Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
    Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The portal circulatory characteristics of patients with esophageal and gastric varices in liver cirrhosis].
    Kotenko OG
    Klin Khir; 1998; (9-10):17-9. PubMed ID: 10050381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatic encephalopathy in cirrhotic patients and spontaneous portacaval anastomosis. Portal angiographic and manometric study].
    Bauret P; Mirouze D; Bories P; Mourrut C; Bruel JM; Michel H
    Gastroenterol Clin Biol; 1989; 13(2):132-5. PubMed ID: 2707522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension.
    Ohnishi K; Chin N; Tanaka H; Iida S; Sato S; Terabayashi H; Nomura F
    Am J Gastroenterol; 1989 Apr; 84(4):409-12. PubMed ID: 2929562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
    Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive evaluation of portal-systemic shunting by glyceryl trinitrate.
    Slanar O; Aubrecht J; Perlík F
    Physiol Res; 2002; 51(4):413-6. PubMed ID: 12449441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.
    Deibert P; Schumacher YO; Ruecker G; Opitz OG; Blum HE; Rössle M; Kreisel W
    Aliment Pharmacol Ther; 2006 Jan; 23(1):121-8. PubMed ID: 16393289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.